Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Teresa Lambe

Associate Professor & Jenner Investigator

Vaccines are efficacious cost-effective healthcare measures and a global mainstay in protecting millions from infectious disease. The establishment of protective immune responses following vaccination and the formation of adaptive immune memory are crucial for ensuring long-lived immunity toward infectious disease.

At the Jenner Institute we have generated viral vectored vaccines efficacious in the establishment of immune memory toward candidate antigens. We continue to develop vaccines against emerging and re-emerging pathogens, including CCHF and Ebolavirus, particularly focusing on the development of vaccines that can confer long-lived protection. A number of these vaccines have progressed through preclinical works and are being assessed in clinical trials.

We are currently focusing on developing a vaccine (ChAdOx1 nCoV-19) against SARS-CoV-2  progressing this vaccine through preclinical assessment and working with OVG on clinical trial testing.